MedPath
NMPA Approval

Mesalazine Sustained-release Granules

国药准字H20143164

March 11, 2024

Drug Information

美沙拉秦缓释颗粒

艾迪莎

颗粒剂

0.5g

化学药品

March 11, 2024

Company Information

Applicant Company

上海市青浦区徐泾318国道16号桥南首前云路278号地块

Manufacturing Company

上海市青浦区徐泾318国道16号桥南首前云路278号地块

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

美沙拉秦缓释颗粒 - NMPA 批准文号 | MedPath